NCT04662554Not yet recruiting
Study of a 1-Millimeter Resolution Clinical Positron Emission Tomography (PET) System in Head and Neck Cancer Imaging
Pilot Study of a 1-Millimeter Resolution Clinical PET System in Head and Neck Cancer Imaging
Source: ClinicalTrials.gov · Last updated 27 Jul 2026
Brief summary (registry, in English)
The purpose of this study is to gain initial experience imaging HNC patient using a new PET camera, a 1mm spacial resolution. The goal is to understand image quality of the system and to see how it works in a clinical environment.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- First submitted
- 6 Nov 2020
- Start date
- Sept 2026
- Primary completion date
- Jun 2027
- Lead sponsor
- Stanford University
- Diseases
- Head and neck cancer
- NCT number
- NCT04662554
What you commit to
- Study type: Interventional
- Planned participants: 10
- From Sept 2026 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 1\. Additional condition, or extenuating circumstance that, in the opinion of the investigator, may interfere with study compliance.
Who the study is looking for
- Biopsy-confirmed diagnosis of HNC
- Patient scheduled to undergo surgery for HNC
- Scheduled to have a PET/CT study on a conventional PET/CT system
- Age greater than or equal to 19 years of age.
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University Coordinator of this site? Confirm its status | Stanford | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.